{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-302022","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2021-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.908639+00:00","generated_at":"2026-06-28T19:58:21.595116+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"NeuroPace appoints Lisa Andrade as Class II director, replacing Evan Norton","bullets":["Evan Norton resigned as Class II director effective Nov 1, 2021; no disagreement cited.","Lisa Andrade appointed as Class II director effective Nov 1, 2021, term through 2023 annual meeting.","Andrade will serve on Audit and Compensation Committees.","She receives a stock option with $185K grant-date fair value, monthly vesting over 3 years.","Annual cash retainers: $40K board, $10K audit, $7,500 compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-302022","json":"https://secwatch.observer/filing/0001193125-21-302022.json","markdown":"https://secwatch.observer/filing/0001193125-21-302022.md","text":"https://secwatch.observer/filing/0001193125-21-302022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/d26236d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T19:58:21.595116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3bed39d7b1","claim":"Lisa Andrade was appointed as Class II director at NeuroPace Inc.","evidence_excerpt":"On October 15, 2021, the Board appointed Lisa Andrade as a Class II director to fill the vacancy created by Mr. Norton’s resignation, effective as of November 1, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"},{"claim_id":"8dc1e68c23","claim":"Evan Norton resigned as Class II director at NeuroPace Inc.","evidence_excerpt":"On October 14, 2021, Evan Norton, a Class II director, resigned from the Board of Directors (the “Board”) (including the Compensation Committee and Audit Committee) of NeuroPace, Inc., effective as of November 1, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312521302022/0001193125-21-302022-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class II director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}